TP53 and acute myeloid leukemia: Similarly, individual TET2 mutations in TP53-mutant AML were subclonal with a variant allele frequency (VAF) of 0.02, but biallelic TET2 mutations or mutations plus deletions in TET2 resulted in much higher VAFs and clonal dominance (Figure 1C).